Astellas to bring OSI fully into the fold by mid-2011
This article was originally published in Scrip
Executive Summary
Astellas expects to complete the integration of its US acquisition OSI Pharmaceuticals by the end of June next year, by which time a number of restructuring moves associated with the transaction will have taken place.